Annexin A1 and A2 in inflammatory bowel disease pathogenesis: exploring new avenues for diagnosis and treatment

Najib Muaamer Faed Murshed, Praveenkumar Shetty, Pavan K. Jayaswamy, Ankeeta Menona Jacob, Samah Saleh Ahmed Alawadhi, Kishan Prasad Hosapatna Laxminarayana · 2026

Read Annexin A1 and A2 in inflammatory bowel disease pathogenesis: exploring new avenues for diagnosis and treatment by Najib Muaamer Faed Murshed, Praveenkumar Shetty, Pavan K. Jayaswamy, Ankeeta Menona Jacob, Samah Saleh Ahmed Alawadhi, Kishan Prasad Hosapatna Laxminarayana (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12808492.txt.

Description

Najib Murshed and colleagues reviewed in 2026 the roles of two proteins, annexin A1 and annexin A2, in inflammatory bowel disease, which covers Crohn's disease and ulcerative colitis. Both proteins shape the NF-kB pathway that drives gut inflammation, but they act in different ways. The review weighs them as diagnostic markers and as treatment targets.

Annexin A1 calms inflammation and helps the gut lining heal. Annexin A2 can either stoke or soothe inflammation, depending on its partners. Both beat a standard marker as blood tests for telling subtypes apart. Drugs that mimic the first protein or block the second are discussed, along with pairing them with existing therapies. Trials are still needed.

Catalog record

CREATORNajib Muaamer Faed Murshed, Praveenkumar Shetty, Pavan K. Jayaswamy, Ankeeta Menona Jacob, Samah Saleh Ahmed Alawadhi, Kishan Prasad Hosapatna Laxminarayana
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12808492

Browse the full library · About the Tower of Babel